Skip to main content

Table 1 Relationship between the expression of PD-L1 and CXCR3 and clinico-pathological characteristics of gastric cancer patients

From: CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer

Clinico-pathological characteristics   Number CXCR3 expression PD-L1 expression
    Low(%) High(%) P value Low(%) High(%) P value
Age(years) <60 42 31(73.8) 11(26.2) 0.343 20(47.6) 22(52.4) 0.675
≥60 50 41(82) 9 (18)   26(52) 24(48)  
Sex Male 72 60(83.3) 12(16.7) 0.025 38(52.8) 34(47.2) 0.312
Female 20 12(60) 8 (40)   8 (40) 12(60)  
pTNM stage I + II 24 18(75) 6 (25) 0.652 7 (29.2) 17(70.8) 0.018
III + IV 68 54(79.4) 14(20.6)   39(57.4) 29(42.6)  
N stage Negtive 23 17(73.9) 6 (26.1) 0.559 10(43.5) 13(56.5) 0.47
Positive 69 55(79.7) 14(20.3)   36(52.2) 33(47.8)  
Lauren classification Intestinal 41 31(75.6) 10(24.4) 0.372 21(51.2) 20(48.8) 0.941
Diffuse 44 34(77.3) 10(22.7)   21(47.7) 23(52.3)  
Mix 7 7 (100) 0 (0)   4 (57.1) 3 (42.9)  
  1. Values shown in bold are statistically significant
\